| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 20.466 | 46.239 | 58.838 | 97.230 | 139.545 |
| Total Income - EUR | - | - | - | - | 0 | 20.466 | 46.240 | 58.839 | 97.232 | 139.548 |
| Total Expenses - EUR | - | - | - | - | 150 | 8.328 | 23.642 | 26.542 | 32.138 | 46.137 |
| Gross Profit/Loss - EUR | - | - | - | - | -150 | 12.139 | 22.597 | 32.297 | 65.093 | 93.411 |
| Net Profit/Loss - EUR | - | - | - | - | -150 | 11.540 | 22.135 | 31.707 | 64.120 | 89.225 |
| Employees | - | - | - | - | 0 | 0 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Cabinet Medical Arpenti S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 13 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 50 | 11.587 | 22.618 | 32.943 | 65.018 | 113.176 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 423 | 21.372 | 49.019 | 100.413 |
| Cash | - | - | - | - | 50 | 11.587 | 22.195 | 11.571 | 15.999 | 12.764 |
| Shareholders Funds | - | - | - | - | -108 | 11.434 | 22.193 | 31.748 | 64.168 | 89.273 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 171 | 153 | 425 | 1.195 | 850 | 23.903 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cabinet Medical Arpenti S.r.l.